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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).SUMMARYLong-QT syndrome mutations can cause syncope and sudden death by prolonging the cardiac action potential (AP). Ion channels
affected by mutations are various, and the influences of cellular calcium cycling on LQTS cardiac events are unknown. To better under-
stand LQTS arrhythmias, we performed current-clamp and intracellular calcium ([Ca2+]i) measurements on cardiomyocytes differenti-
ated from patient-derived induced pluripotent stem cells (iPS-CM). In myocytes carrying an LQT2 mutation (HERG-A422T), APs and
[Ca2+]i transients were prolonged in parallel. APs were abbreviated by nifedipine exposure and further lengthened upon releasing intra-
cellularly stored Ca2+. Validating this model, control iPS-CM treated with HERG-blocking drugs recapitulated the LQT2 phenotype. In
LQT3 iPS-CM, expressing NaV1.5-N406K, APs and [Ca
2+]i transients were markedly prolonged. AP prolongation was sensitive to tetrodo-
toxin and to inhibiting Na+-Ca2+ exchange. These results suggest that LQTS mutations act partly on cytosolic Ca2+ cycling, potentially
providing a basis for functionally targeted interventions regardless of the specific mutation site.INTRODUCTION
Seventy-five times per minute, cardiac action potentials
(APs) propagate the opening and closing of multitudes of
sarcolemmal ion channels. APs arise spontaneously in
sinoatrial nodal cells, spreading through the myocardium
in a sequence. Because APs are complex, they are vulner-
able to ion channel dysfunctions, which often disrupt the
heart rhythm and sometimes end in ventricular fibrillation
and sudden death (Marba´n, 2002).
One disorder resulting from ion-channel dysfunction,
known as long-QT syndrome (LQTS), is characterized by
abnormally long APs and a specific form of tachyar-
rhythmia, Torsade de pointes (TdP), that is precipitated
by physiological triggers or by ‘‘torsadogenic’’ drugs. In-
herited LQTS is considered rare but highly dangerous
because the initial clinical presentation can be sudden
death (Viskin, 1999). Physicians have difficulty treating
LQTS for three principal reasons: (1) assessing the risk of
cardiac events, even within the same family, is confounded
because even the same mutation has differing severity in
different people; (2) for some LQTS mutations, antiar-Stem Crhythmic drugs with maintained effectiveness are lacking;
and (3) the probability of TdP degenerating into ventricular
fibrillation is quite low, creating uncertainty about preven-
tative options. Underlying the incomplete penetrance of
LQTS are both genetic and environmental factors (Bokil
et al., 2010; Vincent, 2003). Consequently, because the
triggering events—and treatments—for LQTS arrhythmias
are mostly gene specific, there is an urgent need for novel
methods of risk assessment (Bokil et al., 2010; Moss and
Kass, 2005; Schwartz et al., 2001).
LQTS is usually diagnosed after unexplained syncopal
(fainting) spells and is confirmed by electrocardiography
that shows a prolonged QT interval (Jackman et al., 1990;
Schwartz et al., 2001; Zareba et al., 1998). Because the
QT interval represents a summation of all ventricular APs,
LQTS mutations primarily affect ventricular ion channel
complexes (Moss and Kass, 2005; Moss and Schwartz,
2005; Viskin, 1999). To date, the study of such mutations
has centered on heterologous expression in nonmyocytes,
but we can now exploit patient-derived induced pluripo-
tent stem cells (iPSCs), offering opportunities to investigate
LQTS mutations in native tissue (Bellin et al., 2013; Inoueell Reports j Vol. 3 j 269–281 j August 12, 2014 j ª2014 The Authors 269
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APs Reflected in Ca2+ Transients of LQTS iPS-CMand Yamanaka, 2011; Itzhaki et al., 2011; Takahashi et al.,
2007; Terrenoire et al., 2013).
Here, we used iPSCs to generate cardiomyocytes by re-
programming skin fibroblasts from two patients carrying
dissimilar LQTS mutations. Associated with LQT2, HERG-
A422T produces trafficking-defective HERG K+ channels
(Kv 11.1) that decrease the rapidly activating delayed recti-
fier current (IKr), which is normally responsible for the bulk
of ventricular repolarization. Conversely, NaV1.5-N406K
produces a net gain of Na+ channel function, associated
with LQT3. By simultaneously measuring membrane
potential (Em) and intracellular free calcium ([Ca
2+]i) tran-
sients, we compared the phenotypes of cardiomyocytes
expressing these mutations. Our studies revealed similarly
remodeled APs, with recurrent early afterdepolarizations
(EADs) mirrored by comparable changes in [Ca2+]i tran-
sients. Such findings may point to a Ca2+-dependent, com-
mon arrhythmogenic mechanism, implying that a single
therapeutic approach may be applicable to multiple forms
of LQTS (Marba´n, 2002; Roden and Viswanathan, 2005;
Viskin, 1999).RESULTS
Fibroblasts, iPSCs, and Cardiomyocytes Reflect the
Patient Genotype
Dermal fibroblasts from LQTS patients and control subjects
were reprogrammed retrovirally into iPSCs (Inoue and
Yamanaka, 2011). We subsequently directed their dif-
ferentiation into cardiomyocytes (iPS-CM) by published
methods (Takahashi et al., 2007; Zhang et al., 2012). The
myocytes formed small groups of typically two to six cells,
termed microclusters, that beat spontaneously. Antibody
labeling and fluorescence microscopy showed that iPS-
CM had protein-expression profiles consistent with a car-
diac lineage, and DNA sequencing showed they carried
the patient’s LQTS mutations (Figures S1 and S2 available
online). Two mutation-positive clones from each patient
were studied in functional assays to accommodate inser-
tional effects in DNA.Functional Characterization of Control and LQT2
iPS-CM
We verified that iPS-CM microclusters were functionally
syncytial by observing that Fluo-4 fluorescence transients
(taken to directly reflect [Ca2+]i) in individual cells were
practically identical around the microcluster and were syn-
chronized at a short 10ms resolution (Figure S3). From this,
we posited that whole-microcluster [Ca2+]i transients (re-
corded by photomultiplier) could be correlated with APs
recorded in any single, syncytial myocyte undergoing
perforated patch clamp. By this convenient method, we270 Stem Cell Reports j Vol. 3 j 269–281 j August 12, 2014 j ª2014 The Autcompared time courses of [Ca2+]i and Em during sponta-
neous beating in control and LQTS myocytes.
Figure 1A (left) shows that in control iPS-CM subjected
to perforated patch clamp, APs were quite brief (APD90:
548 ± 55 ms, n = 14), maximum diastolic potential
(MDP) was negative to 70 mV (72 ± 1 mV) and the
maximum depolarization rate (Vmax) was brisk (45.5 ±
5.5 V/s). The spontaneous beating rhythm was regular,
and [Ca2+]i transients were modestly longer than APs
(FTD90: 759 ± 59 ms, p < 0.001). In LQT2 myocytes, APs
in many microclusters were markedly prolonged and had
multiple EADs. Interestingly, the [Ca2+]i transients faith-
fully reflected this prolonged AP waveform (Figure 1A, cen-
ter and right). Of the two LQT2 cell lines studied, clone A3
tended to have the longer APs and [Ca2+]i transients. In un-
patched A4 microclusters (70% of which showed EADs),
mean [Ca2+]i transient duration (at 90% amplitude) was
1.71 ± 0.31 s (n = 10)—approximately double that of
controls. Results are plotted in more detail for clone A3,
because both APs and [Ca2+]i transients alike were pro-
longedmore than an order ofmagnitude relative to control
(Figure 1B). Even in single LQT2 (A3) myocytes, the shared
trajectory of Em and [Ca
2+]i evoked sustained contractions
(Figure 1C). In both LQT2 clones, the IKr density was about
50% of control (Figure 1D), consistent with the observed
AP prolongation.
The foregoing results suggest that interactions between
Em and Ca
2+-dependent mechanisms might further pro-
long the APD when IKr density is diminished. We therefore
examined the APD changes associated with blocking sarco-
lemmal L-type Ca2+ channels, because IKr tends to oppose
depolarizing Ca2+ current (ICa), especially late in the AP.
Within 30 s of being exposed to 2 mM nifedipine, control
APs were severely abbreviated (and beating ceased) consis-
tent with ICa being the principal source of myocyte Ca
2+
influx (Figure 2A). After the last AP, automaticity failed
to trigger an AP upstroke (Figure 2Aii), and Em was typi-
cally approximately 60 mV until 30 s after nifedipine
was washed out (Figure 2Aiii). As in controls, exposing
LQT2 (A3) iPS-CM to nifedipine abbreviated the APs,
despite the IKr deficit (Figure 2B). However, whereas about
10% (2/19) of LQT2 microclusters stopped beating, most
continued for at least 1 min, unless they were silenced by
applying tetrodotoxin (TTX) to blockNa+ channels (Figures
2C and 2D). In LQT3 iPS-CM, we observed similar results
to controls, where nifedipine caused AP shortening and
arrested beating (Figure S4C). The more sustained auto-
maticity in nifedipine-treated LQT2 iPS-CM may reflect
a specific genetic process in that individual, or perhaps
compensatory automaticity unmasked by the IKr insuffi-
ciency (Itzhaki et al., 2011; Xi et al., 2010).
When a cardiac AP is triggered, ICa evokes a [Ca
2+]i
transient via Ca2+-induced Ca2+ release (CICR) from thehors
Figure 1. Electrophysiological Pheno-
types in Control and LQT2 iPS-CM
(A) Upper: spontaneous APs (Em) recorded
from representative control iPS-CM and the
two clones of LQT2 (as labeled). Lower:
simultaneously recorded [Ca2+]i transients
(red) in arbitrary units (Fluo). Y axes refer
to all traces to the right, and the timescale
bar refers to all traces. Arrowheads point
to EADs.
(B) Mean APD90 and simultaneously ac-
quired FTD90 from control and LQT2 (A3)
microclusters. Grand mean values repre-
sented by horizontal lines were: control,
APD90 0.55 ± 0.05 s and FTD90 0.76 ± 0.06 s
(n = 14); LQT2, APD90 5.80 ± 0.90 s (p <
0.001 versus control) and FTD90 5.89 ±
0.86 s, (p < 0.001 versus control) (n = 10).
(C) Left, top: photomicrograph of a single
LQT2 (A3) iPS-CM (with patch pipette),
scale bar, 10 mm. Clockwise from top right:
AP from the same myocyte; [Ca2+]i tran-
sient (red); cell shortening (blue trace).
The signal durations coincided: APD90 =
6.89 s; FTD90 = 6.89 s; and mechanical transient duration at 90% relaxation (MTD90) = 7.01 s.
(D) Representative families of E-4031-sensitive IKr tail currents (arrows) in control and LQT2 (A4) iPS-CM, and voltage protocol shown
above. The histogram represents peak IKr tail-current densities for control (n = 8), and both LQT2 clones, pooled (n = 19, *p < 0.05).
Error bars (SEM).
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APs Reflected in Ca2+ Transients of LQTS iPS-CMsarcoplasmic reticulum (SR). To model how CICR affects
AP prolongation, we also used 10 mM caffeine to rapidly
release SR-stored Ca2+ into the cytoplasm. In control
microclusters (and in LQT2), we found that sustained
caffeine applications tonically elevated [Ca2+]i, but in-
hibited beating (Figure S4A). Therefore, we employed
caffeine ‘‘puffs’’ to modify [Ca2+]i transients only briefly.
In LQT2 (A4) iPS-CM with modestly prolonged APs,
applying a caffeine puff in diastole (i.e., after repolariza-
tion) triggered an AP (Figures 3A and 3B, left and center).
The triggered AP and [Ca2+]i transient lasted as long as
the caffeine exposure (6 s), regardless of the prior sponta-
neous APD, and the AP lacked prominent EADs (arrow).
Applying caffeine during an ongoing AP (Figures 3A and
3B, right) increased [Ca2+]i and resulted in further depolar-
ization (arrow), likely due to electrogenic Na+-Ca2+ ex-
change (NCX) (Eisner et al., 1998). Scaled APs and [Ca2+]i
transients closely matched in time course, even after
caffeine washout (Figure 3C, arrows), and the durations
of APs affected by caffeine were markedly prolonged (Fig-
ure 3D). Further investigation by Ca2+ imaging showed
that prolonged spontaneous and caffeine-evoked [Ca2+]i
transients occurred simultaneously in each cell of an
LQT2 microcluster (Figure 4). Interestingly, spontaneous
[Ca2+]i transients were also temporarily abbreviated just
after caffeine-induced release of SR Ca2+, potentially indi-Stem Ccating a beat-by-beat feedback of cytosolic Ca2+ on Em,
modulated by Ca2+ extrusion.
To check whether [Ca2+]i transients and APs were always
prolonged together, we exposed control iPS-CM to the IKr
blocker E-4031 (0.5 mM). With an increasing duration of
E-4031 exposure, APs and [Ca2+]i transients became longer
and EADs began to occur, closely mimicking LQT2 (Figures
5A and 5B). APD90 and FTD90 were strongly correlated, and
the beating rate progressively decreased, indicating that
blocking IKr influenced automaticity (Figures 5B and S4B).
To be sure that the effects of E-4031 were due to selective
HERG channel block, we then exposed control iPS-CM
to 10 mM cisapride, which has a distinct mode of action
on IKr (Kamiya et al., 2008). This agent also dramatically
prolonged the [Ca2+]i transients, altering the waveform
to resemble LQT2 and that observed under E-4031
(Figure 5C).
Gain of Function in LQT3 iPS-CM
In LQT3, APs are prolonged by increased inward Na+ cur-
rent, often late in a depolarization (INa,L), rather than by
K+ channel depopulation (Terrenoire et al., 2013). None-
theless, in both LQT3 iPS-CM clones studied, the APs and
[Ca2+]i transients were prolonged together, analogous to
our findings in LQT2 iPS-CM (Figure 6A). Between clones
A1 and A3, the degree of AP prolongation was similar,ell Reports j Vol. 3 j 269–281 j August 12, 2014 j ª2014 The Authors 271
Figure 2. Effects of the Ca2+ Antagonist Nifedipine on Spontaneous APs and [Ca2+]i Transients in Control and LQT2 iPS-CM
(A) Upper panel, time course of APs (Em) during superfusion with nifedipine (gray bar) in a representative control iPS-CM microcluster,
with numerals to indicate regions of interest (ROI). Center and lower panels: labeled ROI shown on an expanded scale.
(B) Upper and center panels, equivalent plots to (A), from a representative LQT2 iPS-CM cluster. Note the increase in beating rate during
nifedipine exposure (gray bar). Lower panel, [Ca2+]i transients (red, labeled Fluo, in arbitrary units) from ROI indicated by numerals above.
(C) APD90 in (A) and (B) plotted against elapsed time, defined by assigning the point of nifedipine addition (gray bar) to time zero.
(Control responses occurred at negative values of elapsed time.) Note that, in the LQT2 microcluster, nifedipine reduced APD90 by 84%
(to 0.71 ± 0.01 s), which was still longer than mean pre-nifedipine APD90 in the control microcluster.
(D) Changes in [Ca2+]i transients (Fluo, in arbitrary units; red trace) when an unpatched LQT2 microcluster was exposed to 2 mM nifedipine
(gray bar), followed by 50 mM tetrodotoxin (TTX) in the continued presence of nifedipine (white bar), which arrested beating. Downward
trace steps represent the blocking of excitation light by the shutter.
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APs Reflected in Ca2+ Transients of LQTS iPS-CMand the relationship between APD90 and FTD90 obeyed a
single linear relation (Figure 6B). For whole-cell patched
LQT3 (A3) cells, where the cytosol was dialyzed with
0.1 mM EGTA to eliminate Fluo-4 dye (Figure 6C, right),
APD90 was prolonged 14-fold relative to control (p =
0.006). Data from perforated patched myocytes were
similar (center), but with shorter mean APD because some-
what fewer APs exceeded 10 s in duration.
LQT3 APs and [Ca2+]i transients often incorporated long
trains of EADs, causing oscillating contractions, possibly re-
flecting a more severe pathology (Movie S1). We therefore
set out to isolate specific effects of N406K channels on
APD by using the selective Na+ channel blocker tetrodo-
toxin (TTX), to which INa,L is highly sensitive (Sakmann272 Stem Cell Reports j Vol. 3 j 269–281 j August 12, 2014 j ª2014 The Autet al., 2000;Wuet al., 2009). In controlmicroclusters, inhib-
iting INa with 50 mM TTX slightly affected the beating
rate and AP morphology but did not significantly shorten
the mean APD90 (Figure 6D). Moreover, in the presence
of TTX, diastolic intervals shortened progressively (after
an initial long pause), whereas the peak depolarization
rate in the AP upstroke (Vmax) continued to be depressed
(beating was later abolished by adding 2 mM nifedipine).
Although TTX reduced Vmax in LQT3 (A3) microclusters,
it also abbreviated APD90 (Figure 6E). During exposure to
1 mM TTX, mean APD90 dropped significantly from 9.79 ±
4.03 to 6.30 ± 3.54 s (p = 0.003, n = 9) and Vmax fell from
54.6 ± 11.3 to 33.9 ± 8.3 V/s (p = 0.006). In response
to 50 mM TTX, mean APD90 decreased even more, fromhors
Figure 3. LQT2 AP Profiles Were Influenced by [Ca2+]i Transients Stimulated by Caffeine-Induced SR Ca
2+ Release
(A) LQT2 (A4) APs (Em) with slight initial AP prolongation (left) or modest AP prolongation (center and right), before, during, and after the
applications of 10 mM caffeine (gray bars). Caffeine was applied in diastole (left, center) or during the ongoing AP (right). Arrows
highlight EADs.
(B) The [Ca2+]i transients (red, in arbitrary units) associated with the APs of (A); gaps in the traces indicate shutter closings.
(C) Overlays of Fluo-4 fluorescence, normalized to the caffeine-induced peak and Em divided by its value at the same time point (peak of
caffeine-induced [Ca2+]i transient). Graphs were produced from traces in (A) and (B). Gray arrows indicate caffeine washout.
(D) APD90 determined beat-by-beat for the entire experiments of (A). Points corresponding to APs affected by caffeine are shown
in gray.
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APs Reflected in Ca2+ Transients of LQTS iPS-CM6.65 ± 1.69 to 2.08 ± 0.68 s (p = 0.008, n = 7), and Vmax,
decreased from 50.3 ± 12.7 to 13.6 ± 1.1 V/s (p = 0.023).
Because high doses of TTX eliminate INa,L, the shortened
APs reveal the gain-of-function in N406K channels. None-
theless, 50 mM TTX only partially returned LQT3 APs to a
duration comparable with control iPS-CM, so direct depo-
larization by mutant Na+ channels could only account for
part of the observed APD. Moreover, EADs continued to
occur while LQT3 myocytes were exposed to 50 mM TTX
(Figure 6E, inset) suggesting that ICa and [Ca
2+]i also partic-
ipated in the LQT3 phenotype. Consistent with this, under
voltage clamp, TTX-sensitive INa,L was 35% of the total
late inward current observed during 500 ms at 10 mV,
whereas the remaining current was nifedipine sensitive
(Figure S5). Furthermore, Vmax calculated for EADs
was<10V/s (analogous to theVmaxofAPupstrokes recordedStem Cwith 50 mM TTX present), suggesting that INa was largely
unavailable during the prolonged AP plateau (Figure S6).
In a previous study in rodent ventricular myocytes, we
used blockers to demonstrate that NCX functionally links
[Ca2+]i and APD (Spencer and Sham, 2003). We therefore
used a similar approach to investigate the phenotype of
LQT3 iPS-CM. First, we confirmed that caffeine-induced in-
creases in [Ca2+]i prolonged the APD (in both LQT3 clones)
as in LQT2 (Figure 7A). Caffeine puffs were also used to
demonstrate inward NCX current (INCX) explicitly, under
voltage clamp (Figure 7B). Interestingly, when INCX was
blocked with LiCl at different times during an ongoing
AP, the AP was rapidly terminated and automaticity halted
(Figures 7C and S4D). Em was hyperpolarized below the
preceding MDP, and [Ca2+]i was elevated above the usual
diastolic level. Both control and LQT2 iPS-CM exposed toell Reports j Vol. 3 j 269–281 j August 12, 2014 j ª2014 The Authors 273
Figure 4. Comparing Spontaneous and
Caffeine-Evoked [Ca2+]i Transients in
Individual Myocytes in an LQT2 Micro-
cluster
(A) Fluo-4 fluorescence averaged in small,
numbered regions of interest (ROIs) each
within a myocyte of an LQT2 microcluster,
plotted (top to bottom) versus time in the
videomicrograph. During the time indicated
by the gray bar, 10 mM caffeine was added
to the superfusion solution.
(B) The numbered ROIs in which fluores-
cence was averaged (yellow rectangles)
superimposed on a transmitted light image
of the microcluster (scale bar, 50 mm).
(C) Overlaid time courses for each ROI
at 30 ms resolution (33 frames/s in
the videomicrograph). The rising phase
of both spontaneous and caffeine-evoked
[Ca2+]i transients superimposed completely.
Similar results were obtained from five
different LQT2 microclusters.
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APs Reflected in Ca2+ Transients of LQTS iPS-CMLiCl exhibited similarly elevated diastolic [Ca2+]i (not
shown). For LQT3 cells, whose mean MDP was 86 ±
2 mV (n = 8), significant hyperpolarization to 93 ±
1 mV (p = 0.002) occurred when LiCl was applied.
LiCl washout abolished the hyperpolarization, allowing
beating to restart. Occasionally at this point, a delay
occurred revealing the restarting of [Ca2+]i transient decay
(previously stalled) ahead of the upstroke of the next AP
(Figure 7D, dotted line). To investigate further if hyperpo-
larization occurred because extracellular Li+ caused NCX
to reverse (with Ca2+ influx andNa+ efflux), the experiment
was repeated after omitting Ca2+ from the Li+-containing
solution (Figure 7E). In the nominal absence of both for-
ward and reverse exchange, we observed that diastolic
[Ca2+]i was still elevated, and Em was hyperpolarized from
79 ± 2 mV (n = 7) to 88 ± 1 mV (p = 0.004), eliminating
NCX as the primary driver of these changes. Premature AP
termination by Ca2+-free Li+-containing solution was asso-
ciated invariably with considerable prolongation of the
next spontaneous AP after returning to control Tyrode’s,
indicating the retention of releasable Ca2+ in the SR.
Conversely, when SR Ca2+ reuptake was inhibited using
50 mM cyclopiazonic acid (CPA), a reversible blocker of
the SRCa2+ ATPase (SERCA), the prolonged lifetime of cyto-
solic Ca2+ could extend the AP essentially indefinitely, with
occasional EADs, terminated by CPA washout (Figure 7F).
These results suggest that cyclical shuttling of Ca2+ ions
across the sarcolemma into the cell via ICa and out via
NCX—with both processes producing depolarizing inward274 Stem Cell Reports j Vol. 3 j 269–281 j August 12, 2014 j ª2014 The Autcurrent—could contribute to the duration of APs affected
by LQTS mutations (even in the absence of CPA).DISCUSSION
This investigation focused on identifying potential mecha-
nisms underlying LQT arrhythmias as recapitulated in my-
ocytes generated from patient-derived iPS cells. The results
complement recent investigations showing that LQTS
phenotypes can be produced in human stem cell-derived
myocytes (Bellin et al., 2013; Davis et al., 2012; Itzhaki
et al., 2011; Lahti et al., 2012; Terrenoire et al., 2013).
Although arrhythmogenic triggers are recognized to be
gene related, prolonged APs are the common denominator
in LQTS diseases (Schwartz et al., 2001). Our results sug-
gest that prolonged APs may promote arrhythmia, at least
partially, through Ca2+-dependent mechanisms.
Though similarities in profile between the AP and [Ca2+]i
transient waveforms might not necessarily indicate a
causal relationship, the results suggest that Em is influenced
by three major Ca2+-dependent mechanisms in combina-
tion. First, blocking ICa strongly abbreviated the APs in
LQT2 iPS-CM, even though AP prolongation had arisen
from IKr deficiency. We attribute this to the normal pres-
ence of a sustained direct depolarization by ICa, and inward
INCX during the triggered [Ca
2+]i transient (Eisner et al.,
1998; Linz andMeyer, 2000; Spencer and Sham, 2003). Sec-
ond, stimulating SR Ca2+ release (with caffeine) during anhors
Figure 5. Control Action Potentials and
[Ca2+]i Transients Were Prolonged by
HERG Blockers
(A) Left: APD90 in a representative control
microcluster plotted against elapsed time,
before and after adding 0.5 mM E-4031 to
the superfusion solution (gray bar). Center:
equivalent plot of FTD90 (in the same mi-
crocluster). Numerals identify individual
traces shown in more detail below. Right:
FTD90 (from center panel) assigned to the
dependent variable and plotted against
APD90 (left panel). For the linear fit:
slope = 0.97 ± 0.03, intercept = 437.64 ±
38.51 ms, R2 = 0.93.
(B) Individual APs (Em, upper panels) and
[Ca2+]i transients (red traces in lower
panels) denoted by numerals in part (A).
These ROI consisted of (i) before expo-
sure to E-4031; (ii) midway; and (iii)
at maximal AP prolongation. Arrowheads
indicate EADs.
(C) Plot of [Ca2+]i transient duration (FTD at
10%–90%) versus elapsed time during an
experiment where a control iPS-CM micro-
cluster was exposed to 10 mM cisapride, a rapidly reversible HERG blocker. Individual, numbered [Ca2+]i transients are displayed below.
Mean duration increased about 10-fold during cisapride treatment (representative of six microclusters).
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APs Reflected in Ca2+ Transients of LQTS iPS-CMongoing AP prolonged its duration, with the resulting AP
reflecting the [Ca2+]i waveform, and blocking SR Ca
2+ reup-
take (via SERCA) prolonged both APs and [Ca2+]i transients
markedly. Thus, our findings support an established mech-
anism whereby a portion of released Ca2+ is extruded,
generating inward INCX and thereby reactivating ICa and
causing EADs (January et al., 1991; January and Riddle,
1989; Makielski and January, 1998). SR Ca2+ reuptake facil-
itates further cyclic Ca2+ releases during EADs, particularly
when Em changes are relatively undamped by repolarizing
currents—as in LQTS—(Figures S6E and S7). Third, in the
presence of LiCl, cytosolic Ca2+ appeared to equilibrate
between the SR and cellular buffers, made evident by the
failure of [Ca2+]i to return to baseline despite membrane
hyperpolarization possibly aided by limited Li+-Ca2+ ex-
change (Doering et al., 1998). When not blocked by LiCl,
forward NCX would likely extrude this Ca2+ load as part
of automaticity (Zahanich et al., 2011). Indeed, depleting
SR Ca2+ by caffeine applications briefly reset spontaneous
LQT2 [Ca2+]i transients to a shorter duration (Figure 4A).
In both LQT2 and LQT3, the occasional prolongation of
APs and Ca2+ transients out to tens of seconds also implies
that mechanisms underlying the refractoriness and restitu-
tion of SR Ca2+ release are readily overridden in iPS-CM (So-
bie et al., 2006). Taken together, our results show that in
human LQTS myocytes (rather than drug-induced LQTS
in animal models) Ca2+ handling is involved in prolongingStem Cthe AP, regardless of the initiating mutation. Although we
encourage additional studies examining a wider range of
LQTS mutations, our results suggest that antiarrhythmic
treatments for LQTS could target cellular Ca2+ cycling,
with the benefit of being genotype independent.
Safe Ca2+ antagonists are already used clinically, and
convincing (albeit limited) evidence supports their use
in LQTS diseases that resist conventional pharmacotherapy
(Iseri and French, 1984; Jackman et al., 1990; Komiya et al.,
2004). However, physicians appear hesitant to prescribe
Ca2+ antagonists in LQTS for fear of triggering vasodilation,
bradycardia, and further arrhythmias. Conversely, evi-
dence from animal models favors these agents (Bailie
et al., 1988; Guo et al., 2007; Thomas et al., 2007; Yamada
et al., 2008). One study suggested that mere 5 mV shifts in
ICa activation or inactivation voltage might abolish EADs
(Madhvani et al., 2011). Direct injection of MgSO4 also ter-
minates TdP effectively, but this is unsuitable for daily ther-
apy (Johnson et al., 2001; Viskin, 1999). Interestingly,Mg2+
may be efficacious because it blocks both ICa and SR Ca
2+
release, but little is known about what controls the level
of this ion intracellularly (Eisner et al., 1998; Iseri and
French, 1984; Wang et al., 2004).
Compared to other types of LQTS, LQT3 is themost lethal
(Bankston et al., 2007; Terrenoire et al., 2013; Zareba et al.,
1998). Our results suggest that the LQT3 phenotype can be
complex, depending directly onmutant Na+ channels, andell Reports j Vol. 3 j 269–281 j August 12, 2014 j ª2014 The Authors 275
Figure 6. Phenotype and Pharmacology of LQT3 iPS-CM
(A) APs (Em in mV, top) and [Ca
2+]i transients (Fluo in arbitrons, bottom) from microclusters representative of the two LQT3 clones
(as labeled). Axes refer to traces to the right, and timescale bar refers to all traces.
(B) Plots of FTD90 versus APD90 from clone A1 (filled symbols) and A3 (open symbols) on the same axes, with a combined linear fit:
slope = 1.03 ± 0.07, intercept = 0.25 ± 0.02, R2 = 0.99.
(C) Dot plot showing APD90 from microclusters under whole cell mode (WC, closed symbols) and perforated patch clamp (PP, open symbols)
in control (stars), LQT3 clone A1 (triangles), and LQT3 clone A3 (circles). Means were nonsignificantly different between LQT3 clones, or
between PP and WC in any single cell type. Lines represent the overall mean in each category (combined in Table S1).
(D) Left: APD90 in a representative control microcluster when exposed to 50 mM TTX (gray bar), and later after adding 2 mM nifedipine
(black bar). Introducing TTX initially interrupted beating for 51 s (mean pause 24 ± 7 s, n = 7), but recovery followed. Right: Vmax for
upstrokes (in the same APs) diminished from 134.5 ± 4.8 V/s to 17.9 ± 0.3 V/s in TTX. Inset: sample APs before (broken trace) and during
(solid trace) TTX exposure showing that TTX altered the AP profile, leaving APD90 unchanged.
(E) Left: APD90 changes, equivalent to (D), in an LQT3 (A3) microcluster during exposure to 1 mM TTX (white bar), 50 mM TTX (gray bar), and
50 mM TTX plus 2 mM nifedipine (black bar). Right: Vmax plot in the same LQT3 microcluster. Inset: APs before (broken trace) and during
exposure to 50 mM TTX (solid trace).
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APs Reflected in Ca2+ Transients of LQTS iPS-CMpartly on other conductances. ICa made up most of the
measurable late inward current in LQT3 iPS-CM, substanti-
ating the possibility that blocking this current (for which
persistence is known) could be specifically useful in LQT3
(Linz and Meyer, 2000; Thomas et al., 2007). However,
doubts have been expressed about whether studies using
stem cell-derived myocytes are directly applicable to real-
life medicine, because such cells are acknowledged to be
relatively immature (Doss et al., 2012; Lieu et al., 2009).
On the other hand, immaturity and spontaneous beating276 Stem Cell Reports j Vol. 3 j 269–281 j August 12, 2014 j ª2014 The Autin stem cell-derived myocytes has not prevented the suc-
cessful development of assays for arrhythmogenesis, with
some producing traces similar to ours (Abassi et al., 2012;
Changet al., 2012; Terrenoire et al., 2013). Becausewecould
not fully constrain automaticity by electrical pacing, future
studies would be aided by fuller elucidation of the underly-
ing mechanisms or uncovering which transcription factors
are required for complete iPS-CM differentiation.
Another issue relates to the choice of appropriate controls
in a disease with incomplete penetrance, as highlighted byhors
Figure 7. The Role of Cytosolic Ca2+ in the LQT3 Phenotype
(A) Representative LQT3 (A3) APs (top) and [Ca2+]i transients (bottom) before (left) and during (right) exposure to 10 mM caffeine
(gray bar). Axes refer to traces to the right, and timescale bar refers to all traces (representative of ten LQT3 (A3) and four LQT3 (A1)
microclusters).
(B) Inward current (top trace) recorded, at 80 mV, from an LQT3 (A3) myocyte under perforated patch, during a caffeine puff (gray bar)
that evoked SR Ca2+ release (lower panel). Li+ sensitivity (not shown) confirmed this current as INCX (n = 5).
(C) A prolonged LQT3 (A3) AP was rapidly terminated after most extracellular NaCl (except 5 mM) was replaced by with LiCl (black bar). Em
was hyperpolarized, cytosolic Ca2+ was tonically elevated, and Li+ washout evoked another AP. Results were similar in eight replicate
microclusters.
(D) In a different preparation, the AP accompanying LiCl washout was more delayed, fortuitously revealing that unblocking INCX produced
Ca2+ efflux and a simultaneous depolarization (dotted line).
(E) LiCl, applied in Ca2+-free extracellular solution (black bar) to additionally eliminate outward INCX, terminated LQT3 (A1) APs, as in (C)
(n = 8). The AP associated with Li+ washout was markedly prolonged relative to prior APs (labeled ‘‘control’’).
(F) Time course of LQT3 (A3) APs (upper panel) and [Ca2+]i transients (lower, red trace) during exposure to 50 mM cyclopiazonic acid (CPA)
to block SERCA (gray bar). A slowly decaying, prolonged plateau of cytosolic Ca2+ established a corresponding long depolarization,
proceeding beyond CPA washout. Gaps in the fluorescence trace correspond to shutter closures. (Representative of five microclusters
showing similar responses.)
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APs Reflected in Ca2+ Transients of LQTS iPS-CMour finding that LQT2 iPS-CM were relatively resistant to
nifedipine compared to the other genotypes. Mitigating
this, whenwe exposed controlmyocytes to HERG blockers,
the resultingmarked AP prolongationmodeled LQTS in the
absence of a genetic modification.Moreover, in the present
studies and in somepublishedfindings, patient-derived iPS-
CM lines exhibited exaggerated LQTS phenotypes as
compared to clinical experience—though electrotonic and
other passive effects alter the observable disease manifesta-
tions in organized tissue. Other groups found mild LQTSStem Cphenotypes, even in isogenic LQTS lines, and we found
less dramatic AP prolongations in large colonies >100myo-
cytes (Bellin et al., 2013; Itzhaki et al., 2011; Matsa et al.,
2011). Because microcluster control APDs closely matched
published values from intact ventricles (Khan et al., 2010;
Terrenoire et al., 2013), we suspect that a more hyperpolar-
ized MDP may have produced a more physiologically
appropriate resting state, evidenced by a generally large
Vmax for AP upstrokes (see Table S1). Arguably, this led
to heightened responses to LQTS mutations and toell Reports j Vol. 3 j 269–281 j August 12, 2014 j ª2014 The Authors 277
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APs Reflected in Ca2+ Transients of LQTS iPS-CMtorsadogenic drugs. Initially, we obtained MDP no deeper
than 65 mV (similar to other studies), but as our differen-
tiation technique improved, the myocytes matured devel-
opmentally (Bellin et al., 2013; Doss et al., 2012; Itzhaki
et al., 2011; Zhang et al., 2012). Moreover, isolated myo-
cytes are likely to show more severe phenotypes due to
the lack of compensatorymechanismspresent in thenative
circulatory system. Finally, in validating the functionally
syncytial nature of myocyte microclusters, we were also
able to show that brief APs were associated invariably with
brief [Ca2+]i transients, and vice versa.
Prolonged APs and EADs are typical of pharmaco-
logically induced LQTS modeled in nonhuman hearts
(Shimizu and Antzelevitch, 2000; Studenik et al., 2001; Ter-
entyev et al., 2014), yet few such studies examined [Ca2+]i
transients. The lengthening of APs and [Ca2+]i transients
after pharmacologically blocking IKr in control iPS-CM,
in direct parallel to animal studies, well corroborates our
evidence from LQTS myocytes. Insights such as this sug-
gest that benefits may accrue from routinely deriving iPS-
CM from LQTS patients, both for risk assessment, and to
guide treatments including whether to employ Ca2+ chan-
nel blockers (Terrenoire et al., 2013). In conclusion, our
results contend that existing or novel Ca2+ antagonists
(perhaps acting to shift the level of cytosolic Mg2+) may
help us to reduce the risk of cardiac events in the LQTS
population.EXPERIMENTAL PROCEDURES
Patient Recruitment and Characteristics
TwoLQTSpatients and two control individuals, who suppliedwrit-
ten consent forms, were biopsied for dermal fibroblasts. All proto-
cols were approved by the Committee on Human Research at the
University of California, San Francisco, and conformed to the
declaration of Helsinki principles. Patient 1, a 54-year-old female
with LQT2 and QTc of 493 ms on surface electrocardiogram (Fig-
ure S1A), initially presented with unexplained syncope. Genetic
testing revealed a heterozygous A422T mutation (1264G > A) in
the HERG K+ channel (gene: KCNH2). Patient 2 was born with
QTc of 523 ms and had had a pacemaker implanted to address
bradycardia and TdP (Figure S1A). A de novo N406K (1218C > A)
mutation in NaV1.5 (gene: SCN5A) led to diagnosis of LQT3. This
patient unfortunately passed away during sleep, a year after her
skin biopsy (aged 19). Two unrelated individuals without pre-exist-
ing disease or arrhythmia provided tissue samples for control iPSC
lines. Both subjects had normalQT intervals (QTc < 450ms). Fibro-
blasts from all skin biopsies were isolated, expanded and later
banked under liquid nitrogen.Production and Differentiation of iPSCs
Fibroblasts were reprogrammed and differentiated using minor
modifications to the protocols listed in Supplemental Experi-
mental Procedures (Takahashi et al., 2007; Zhang et al., 2012).278 Stem Cell Reports j Vol. 3 j 269–281 j August 12, 2014 j ª2014 The AutFor each patient genotype, two clones were used for functional
studies (named A3 and A4 in LQT2, A1 and A3 in LQT3).Electrophysiology
At least 30 days postdifferentiation, visibly beating myocytes were
dispersed by trypsinization onto fibronectin- or gelatin-coated
coverslips (no. 1, CS15R, Warner Instruments). Populated cover-
slips were incubated in RPMI complete medium (changed every
3 days), and were transferred to the superfusion bath (Warner
RC-26GLP) on a Nikon TiS inverted microscope equipped with
a photomultiplier (PMT) microfluorometer (IonOptix, PMT400)
and motion detector (VED, Crescent Electronics). Extracellular
solutions, delivered locally near the patch-clamp electrode, were
warmed to 30C with a superfusion system (AutoMate Scientific).
One myocyte of a synchronously beating microcluster was
patch-clamped, while fluorescence was recorded simultaneously
from the entire microcluster. Whole-cell and perforated patch
clamp were employed in different experiments. An Axopatch
200B amplifier (Molecular Devices) was coupled via pClamp
software (v10) to patch electrodes of 2–3 MU (1B-150F; WPI)
filled with intracellular solution containing (mM): 120 KCl, 20
NaHEPES, 10 MgATP, 0.1 K2EGTA, 2 MgCl2, set to pH 7.1 with
KOH. Perforated patch was used to record from Fluo-4 loaded my-
ocytes after adding 240 mg/ml of amphotericin B plus 5 mM EGTA
to the same pipette solution (Rae et al., 1991). If [Ca2+]i transients
were absent or diminished (due to patch rupture, allowing EGTA to
chelate cytosolic Ca2+) the experiment was terminated. Myocytes
were superfused at constant flow (W2-64, Warner Instruments)
with modified Tyrode’s solution containing (mM): 137 NaCl, 10
NaHEPES, 10 dextrose, 5 KCl, 2 CaCl2, 1 MgCl2. This solution
was set to pH 7.4 with NaOH. NCX was inhibited by replacing
external NaCl with 137 mM LiCl, and in some experiments,
CaCl2 was omitted with no ionic substitution. In pharmacological
experiments, drugs (caffeine, cisapride, E-4031) were obtained
from Sigma or Ascent Scientific and the level of DMSO vehicle
was <1%. The Axopatch amplifier was set to current clamp at
zero applied current, and spontaneous APs were recorded for 30 s
per data file.
Sodium current (INa) was recorded from single myocytes with
high EGTA intracellular solution (as above) in which K+ was re-
placed by Cs+. Rapid delayed rectifier K+ current (IKr) wasmeasured
after dialyzing with intracellular solution containing (mM)
130 KCl, 1 MgCl2, 5 EGTA, 5 MgATP, 10 HEPES (pH 7.2 with
KOH). The HERG-related tail current was quantified by difference
(Figure 1D) using extracellular solution (with and without 5 mM
E-4031) containing (mM): 137 NaCl, 4 KCl, 1.8 CaCl2, 1 MgCl2,
10 glucose, and 10 HEPES (pH 7.4 with NaOH).Intracellular Ca2+ Measurements
Myocytes on coverslips were loaded with the Ca2+ indicator dye
Fluo-4 AM, before transfer to the superfusion chamber. Loading so-
lution contained a 1:10 mixture of 5 mM Fluo-4 AM in dry DMSO
and Powerload concentrate (P10020, Invitrogen), diluted 100-fold
into extracellular solution and substituted for the culture medium
(5mMfinal [Fluo-4]). Loadingproceeded for 20minat roomtemper-
ature, followed by 20 min in dye-free extracellular solution for de-
esterification before commencing recordings. Ca2+ transients werehors
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APs Reflected in Ca2+ Transients of LQTS iPS-CMrecorded via a standard filter set (#49011 ET, Chroma Technology).
Between samplingperiods, excitation lightwasblockedby a shutter
(CS35, Vincent Associates). Background fluorescence was recorded
after removing the cell(s) from the field of view. Fluo-4 AMwas pur-
chased from Molecular Probes (Invitrogen). In some experiments,
the PMT system was replaced by a high-resolution, fast charge-
coupled device camera (MiCam02, SciMedia) to visualize [Ca2+]i
transients by videomicroscopy. Frame rates of 30–100 fps were
used. Movies were analyzed with Image J software (http://rsbweb.
nih.gov/ij/).
Electrophysiological Data Analysis
APs were digitized at 5 kHz and low-pass filtered at 2 kHz. Every
consecutive AP (and [Ca2+]i transient) was measured in each data
sweep. The median number of files defining an APD phenotype
was three, corresponding to 90 s of continuous recording (45 APs
at 0.5 Hz). The maximum depolarization rate in the AP upstroke
(Vmax) was calculated using OriginPro 8.6 software (OriginLab) or
Clampfit (pClamp 10, Molecular Devices). AP amplitude and dura-
tion, determined between the upstroke (at Vmax) and 90% repolar-
ization (APD90), were determined using in-house analysis routines
in Excel 2007 (Microsoft), with correction for a 5.6 mV liquid
junctionpotential.Microclusterswith amaximumdiastolic poten-
tial (MDP) positive to 65 mV were eliminated from analysis. The
time course of [Ca2+]i-dependent fluorescence transients was quan-
tified as the duration at 10% amplitude (10%–90% time); or for
correlation with APD90, as FTD90, based on the duration at 10%
amplitude measured from Vmax of the AP (coincident with the
upswing of the fluorescence transient). To avoid movement arti-
facts in fluorescence recordings, cells and microclusters were
framed by a cell-free border and bright-field images were recorded.
In some experiments, cell motion was quantified from video-
micrographs using an edge-detector algorithm written in LabView
(National Instruments), calibrated using a stage micrometer. All
statistical comparisons were performed using two-tailed, paired,
or unpaired t tests. Mean values are presented with standard errors
(mean ± SEM), and the numbers of replicates indicate numbers of
independent microclusters constituting the mean.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
Procedures, seven figures, one table, and one movie and can be
found with this article online at http://dx.doi.org/10.1016/j.
stemcr.2014.06.003.
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